Investor Resources 2022 Annual General Meeting Documents for year end 2021 – January 20, 2022 – Certificate of Abridgement January 20, 2022 – Management Information Circular fiscal July 31 2021 January 20, 2022 – Notice of Meeting Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) Profile (sedar.com) Recent News Events and Presentations Corporate Presentation
